The novel biomarker neutrophil gelatinase-associated lipocalin (NGAL) shows great promise as a prognostic indicator in COVID-19 patients in the emergency department1,2 and ICU3–5 as well as in other critically ill patients6–11. Here, LCN2 is linked to COVID-19.